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Abstract: Aim and objective: To describe the study design of a randomised controlled trial with the aim of comparing two 
different regimes for children with newly diagnosed type 1 diabetes; hospital-based care and hospital-based home care. 
Background: Procedures for hospital admission and sojourn in connection with diagnose vary greatly worldwide and the 
existing evidence is insufficient to allow for any conclusive determination of whether hospital-based or home-based care 
is the best alternative for most families. Comparative studies with adequate power and outcome measurements, as well as 
measurements of cost-effectiveness are needed. 
Design: The study design was based on the Medical Research Council framework for complex interventions. After two to 
three days with hospital-based care, children between the ages of 3 and 16 were randomised to receive either continued 
hospital-based care for a total of 1-2 weeks or hospital-based home care, which refers to specialist care in a home-based 
setting. The trial started in March 2008 at a University Hospital in Sweden and was closed in September 2011 when a 
sufficient number of children according to power calculation, were included. The primary outcome was the child’s 
metabolic control during the following two years. Secondary outcomes were set to evaluate the family and child situation 
as well as the organisation of care. 
Discussion: Childhood diabetes requires families and children to learn to perform multiple daily tasks. Even though 
intervention in health care is complex with several interacting components entailing practical and methodological 
difficulties, there is nonetheless, a need for randomised controlled trials in order to evaluate and develop better systems 
for the learning processes of families that can lead to long-term improvement in adherence and outcome. 
Trial Registration: Trial Register NCT00804232. 
Keywords: Type 1 diabetes, disease management, family, research design, randomised controlled trial, haemoglobin A1c. 
INTRODUCTION 
  Type 1 diabetes is one of the most common chronic 
diseases in children and adolescents. It is a serious and 
expensive disease with a risk for late complications [1, 2]. 
Research during the last decade has provided a substantial 
amount of evidence for the relation between family factors 
and metabolic control [3-7]. The Swedish national guidelines 
for paediatric diabetes [8] have existed since the 1980s, 
providing consistent, high standards and important contribut-
ions to Swedish paediatric diabetes care. Recommendations 
of the Swedish national guidelines for paediatric diabetes 
include hospital-based care at the time of diagnosis and 
intravenous insulin treatment for the first days even if the 
child is not acutely ill. There are few recent studies that 
describe hospital admission procedures for children with 
newly diagnosed type 1 diabetes. However, previous 
descriptions show that hospital admission and sojourn at the 
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time of diagnosis varies greatly worldwide, from several 
weeks to a few days or completely on an outpatient basis [9-
14]. 
  The often negative impact of hospital admission on 
children and their families calls for alternative ways of 
providing care [15, 16]. Paediatric home care (PHC) 
facilitates the continuation of normal life for children and 
their families and is on the increase due to the potential 
psychosocial benefits of home care and the costs of hospital-
based health care [17]. There is no consensus on the 
definition of PHC and the service can be based on both 
general and specialist schemes. General PHC services most 
often work from a community base in a single district. By 
contrast, specialist services are more likely to be hospital-
based, providing service to more than one district [17-20]. 
Outpatient treatment is provided by health care professionals 
in the outpatient clinic at the hospital while PHC provides 
treatment by health care professionals in the child’s home. 
Hospital-based home care (HBHC) refers to specialist care in 
a home-based setting. The existing evidence is insufficient to 
allow for any conclusive determination as to which process, 
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when diagnosed with type 1 diabetes. Comparative studies 
with adequate power and outcome measurements, with cost-
effectiveness measurements and with a follow-up of at least 
two years, are needed [18, 21]. 
BACKGROUND 
  The goals of initial treatment and management are for the 
child to attain metabolic balance and for the families to 
understand the illness and learn how to manage the 
treatment. Clinical practice consensus guidelines of the 
International Society for Pediatric and Adolescent Diabetes 
(ISPAD), with the current views of experts in the field [22] 
are being used to assist clinicians in managing childhood 
diabetes. ISPAD’s guidelines state that health professionals 
should deliver structured education using behavioural 
learner-centred approaches rather than didactic approaches 
[23]. Both ISPAD’s and national paediatric guidelines 
emphasise the importance of individualised support and 
education by a diabetes specialised team [8, 24-26]. 
Educational interventions have shown an effect on 
psychosocial outcomes and a modestly beneficial effect on 
metabolic control [27, 28]. Interventions based on clear 
theoretical psycho-educational principals, involving the 
whole family and making use of techniques such as problem 
solving, goal setting, coping skills and stress management 
are most likely to be effective [4, 23, 27, 29]. 
  An optimal research situation would be for scientists to 
be able to introduce an intervention under circumstances in 
which no other variables could be confounded with the 
introduction. However, full control and full isolation of the 
intended treatment is seldom possible. Complex intervention 
in health care often comprises a number of components, 
which may act both independently and interdependently. The 
number of components, including behaviour both of those 
delivering and receiving the intervention, the flexibility of 
the intervention and the variability of outcomes are 
dimensions of the complexity of the intervention [30, 31]. 
With a random assignment the plausibility of alternative 
explanations for observed effects is reduced. This is 
presuming that the procedure of randomisation has been 
carried out correctly, and that the groups are equal, not only 
at the time of randomisation, but also at the time of the 
follow-up, in all aspects other than the actual treatment. A 
further condition for the evaluation of the effectiveness of an 
intervention is that the treatment that was intended becomes 
the treatment actually received, not only partially received. 
There is always a risk for interventions to slide such as, for 
example, if the participants in the intervention group and the 
control group respectively, converse and thereby receive 
partial access to both treatments, so-called “nesting” [32]. 
  There are promising results from interventions with the 
aim of empowering individuals to manage their own health. 
However, it is often not clear which are the active 
ingredients of many successful interventions [27, 33, 34]. 
Furthermore, in order to comprehend and assess the validity 
of a randomised controlled trial (RCT), readers must 
understand the design, conduct, analysis and interpretation of 
the study [35-37], which requires a comprehensive 
description for complex interventions, based on a clear 
theoretical framework [30, 31]. 
 
Theoretical Framework 
  A number of family patterns of interaction that can 
substantially impact on the intellectual development of 
young children are identified. Guralnick [38] presents three 
family patterns influencing the developmental outcomes of 
children: 
•  The quality of parent-child transactions, described as 
a sensitive responsiveness. The parents see, listen to 
and encourage the child in a discourse-based and non-
intrusive way. 
•  Family-orchestrated child experiences: The parents 
take responsibility for organising home and 
community experiences; the home environment 
contains stimulating toys and experiences adequate 
for the child’s age. 
•  Health and safety is provided by the family; providing 
proper nutrition and ensuring the child’s safety is also 
essential for the child’s development. 
  Family characteristics, such as intellectual disabilities or 
poor health, as well as a lack of financial resources and 
social support can create stressors. As can the child’s 
characteristics associated with his/her biological 
vulnerability, such as, for example, diabetes or other chronic 
illnesses. These stressors are capable of perturbing even 
optimal family patterns of interaction. Potential stressors for 
families created by the child’s disability or illness are the 
parents’ need for information, interpersonal and family 
distress, as well as the parents’ lack of confidence and 
resources [38]. It is presumed to be the cumulative effect that 
produces the greatest threat to children’s physiological and 
mental health [39]. When considering risk factors regarding 
poor metabolic control, the greatest risk would be for 
children in families that are already exposed to general 
stressors, besides the stressor caused by the child’s diabetes. 
  This article describes the study design and outcome 
measurements of a randomised controlled trial with the aim 
of comparing two different regimes for children with newly 
diagnosed type 1 diabetes; hospital-based care and hospital-
based home care. 
MATERIALS AND METHODOLOGY 
  The study design is based on the Medical Research 
Council framework for development and evaluations of 
RCTs for complex interventions to improve health [30, 31]. 
The framework distinguishes five phases; the first phase is 
theoretical and the second is about developing an 
understanding of the components in the intervention. In the 
third phase, the intervention can be explored or tested. The 
fourth phase includes an RCT with adequate power and 
appropriate outcome measurements. The fifth and final step 
in the evaluation of a complex intervention is long term 
surveillance in order to study the real-life effectiveness of 
the intervention. 
  Qualitative research is helpful for identifying critical 
components of importance for the intervention [30, 31]. In 
the first pre-clinical phase, we elaborated the theoretical 
framework with a literature review of the results of families’ 
experiences of living with childhood diabetes from the time  
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of diagnosis and through the following three years [15, 16, 
40, 41]. The studies indicated that the time after diagnosis is 
a difficult time for the whole family, characterised especially 
by the need for information and for resources to learn how to 
live with the illness as well as by difficulties in maintaining 
the diabetes regime [16, 40, 41]. Theoretical information is 
not always easily transformed into practical skills and 
experiences; a “learning by doing” approach is more likely to 
lead to knowledge acquisition than an entirely theoretical 
approach. This phenomenon was first described by John 
Dewey [42, 43], but Donald Schön [44] established the 
concept during the 1980s. Reflection together with others 
may elucidate tacit knowledge. Limitations imposed on 
families due to the diabetes treatment might not be as severe 
as they initially appear, and stressors created by the illness 
can often be avoided by practical advice and by appropriate 
timing within the treatment. What the family is initially 
taught and the way of living with diabetes that is first 
presented to them, will be experienced by them as the right 
way and it will be more difficult to maintain a regime the 
more it diverges from the family’s natural lifestyle. 
  In the second phase, the components of the intervention 
were identified and explored from a second literature review 
and from interviews with the parents of children with type 1 
diabetes as well as with professionals working in the 
diabetes team, in order to develop an understanding of the 
components in the intervention and how they may 
interrelate. A home-based environment was presumed to 
move the responsibility for the diabetes treatment from 
health care professionals to the family with increased family 
participation as a consequence. Participation was likely to 
raise an extended need for practical knowledge that might 
facilitate for the family to put theory into practice [42, 44]. A 
home-based environment was also presumed to make the 
family’s personal lifestyle visible to health professionals, 
allowing for strengths and difficulties to be taken into 
consideration in creating an individualised learning process 
and for making good use of available resources. The study 
and the randomised design were planned and instruments 
were translated and tested [45]. 
  In the third phase, the intervention was explored with a 
pilot study where study design and logistics were tested. 
Parents of two children, newly diagnosed with type 1 
diabetes, were informed about the study and asked for 
consent for the pilot study. Parents and children in both 
families consented and received hospital-based home care 
according to the study design. No adjustments of the study 
design were needed. However, some clarifications for the 
procedure were made concerning which person would be 
best suited to inform the families about the study and to ask 
for informed consent. The fourth phase included the main 
randomised controlled trial, with adequate power calculation, 
randomisation, treatment protocol and informed consent of 
the participants. The main trial started in March 2008 and 
was closed in September 2011 when a sufficient number of 
children, according to power calculation, were included. A 
flow diagram of the progress through the phases of the main 
trial is shown in Fig. (1). 
  The study was registered at clinicaltrials.gov with the 
identity number NCT00804232 and follows the CONSORT 
(Consolidated Standards of Reporting Trials) recommendat-
ions, a statement issued in order to improve the reporting of 
RCTs [35-37]. The study was approved by the Research 
Ethics Committee at Lund University (LU 305/2007). 
Setting 
  The trial took place at a University Hospital in Sweden. 
The Hospital has a catchment area with a population of 71 
684 (December  2010) children and adolescents from 0-18 
years [46]. The diabetes department unit cares for about 250 
children and adolescents; aged 0-18 (in 2010), and 
approximately 25-30 children are diagnosed with type 1 
diabetes per year [47]. The diabetes team members included 
diabetes specialised paediatric nurses (from now on called 
diabetes nurses), paediatricians specialised in paediatric 
diabetes (from now on called paediatricians), a dietician and 
a social worker. A psychologist was available for families 
with special needs and was consulted by the diabetes team 
Fig. (1). Flow diagram of the progress through the phases of the trial until September 2011, when the trial was closed. 
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when relevant. According to Swedish law, parents of 
children who are ill have the possibility of receiving a 
parents’ allowance during the child’s care. When a child is 
diagnosed with diabetes the period for this allowance also 
includes another 2-3 weeks after discharge for both parents. 
Agreements for financial compensation concerning the 
parents’ allowance include about 80 % of the parents’ salary 
up until the level of a predetermined salary ceiling. 
  Due to organisational factors, and in order to facilitate for 
the family, a form of care was chosen for the HBHC 
intervention group that would be familiar both to health 
professionals at the Children’s Hospital and to the families, 
namely The Family House. The Family House offers sick 
children and their families a home-like environment and is 
placed in the hospital area. There is room for 20 families and 
each family has one room where the whole family, including 
siblings, can stay together. Parents make their own meals 
and there are spaces for children to be physically active. 
Participants 
  Children from 3-16 years of age, who are newly 
diagnosed with type 1 diabetes at the University Hospital, 
without any other difficult chronic illnesses or siblings with 
type 1 diabetes, living in a Swedish speaking home and not 
in custody of social care, were candidates for inclusion in the 
study. The age span of 3-16 years was chosen because it was 
not considered safe to include the youngest children and 
there was a transition to the adult diabetes care setting when 
the adolescent was 18 years. A follow-up of two years set the 
limit at a maximum of 16 years of age for inclusion. 
Children in both groups received, as inpatients, intravenous 
treatment to attain metabolic balance, and followed the 
Swedish national guidelines for children newly diagnosed 
with diabetes [8] during the first two or three days. When the 
child was medically stable, families received subsequent care 
according to their randomisation. At the time of discharge 
and irrespective of randomisation, the paediatrician 
completed the Psychosocial Assessment Tool (PAT) [48], an 
instrument for identifying psychosocial risk factors at 
diagnosis to predict the subsequent use of psychosocial 
resources, based on the judgement of the diabetes team. 
After discharge, all families followed the regular diabetes 
check-ups with visits at the outpatient department unit after 
about 1, 3 and 6 weeks. Gradually the visits thinned out to 
every third or fourth month, which was the frequency of the 
continued visits. 
  Members of the diabetes team asked the parents if a 
researcher could come and inform about the study. If the 
parent consented, one of the investigators provided verbal 
and written information about the study within 48 hours of 
the diagnosis. Children were age-appropriately informed 
verbally and children who were 12 years or older also 
received age-appropriate information in writing. The families 
were then given time for consideration (12 hours) before the 
parents and children over the age of 12 were asked for 
consent. Children under the age of 12 were asked for assent. 
If the parents and child consented/assented, the child was 
randomised to either hospital-based care or HBHC. 
Randomisation 
  The children were randomised in two strata, younger than 
eight years or eight years and older. The randomisation was 
performed by an independent centre for clinical research 
using the software R-2.6.1 [49]. Within each stratum 
children were assigned to the two different treatments by 
sampling without replacement from a block consisting of, to 
the investigators, unknown number of labels from each 
treatment group. The seed of the random number generator 
was stored. According to the routine procedure for RCT in 
clinical settings the investigators received two sets of coded, 
sealed and opaque envelopes, one set for older children and 
one for younger children. The envelopes were identical and 
contained one of two possible instruction sheets, “Hospital-
based care” or “HBHC”. 
Sample Size 
  HbA1c was the primary objective two years after 
diagnosis, when the endogenous insulin production had 
ceased for most children. A difference in HbA1c of 
10mmol/mol was estimated as clinically relevant and 
statistical power was calculated on a known variation in 
HbA1c during the first two years after diagnosis. During 
1997-2006, 247 children who were 3-16 years old at the time 
of diagnosis showed a standard deviation of 14mmol/mol in 
individual HbA1c measurements. To show a mean difference 
of 10mmol/mol between two groups, it took 30 children in 
each group with a power of 0.79, and a significance level of 
5%. 
Fig. (2). Time axis of the trial and follow-up. 
 
 
March 2008 
Trial start 
September 2011 
Trial closed
6 monthf ollow-up
12 month follow-up
24 monthf ollow-up
Follow-up at discharge Randomised Controlled Trial Comparing Hospital-Based Care  The Open Nursing Journal, 2011, Volume 5    115 
Hospital-Based Care 
  Children randomised to hospital-based care followed the 
routine care at the hospital which involved a total of 1-2 
weeks of hospital-based care. The child with diabetes and the 
child’s parents’ were called to information meetings with the 
diabetes team members during the hospital stay. The 
paediatrician, the dietician and the social worker usually had 
3-4 meetings with each family and the diabetes nurse had 4-8 
meetings. Each meeting lasted for about 30-60 minutes. The 
information followed a checklist, based on Swedish national 
guidelines for paediatric diabetes, where each discipline was 
responsible for different portions of education on the 
checklist. One parent could stay at the hospital with the child 
during the night. The other parent was encouraged to be 
present during the educational sessions. The child could 
leave the ward in the daytime between meetings when 
parents felt secure in their management of hypoglycaemia 
and if they had an agreement with the responsible 
paediatrician. Towards the end of the hospital stay, the 
family returned to their home for two-three days until 
discharge. During these days, the family reported, by phone, 
the child’s glucose levels for the previous 24 hours and 
received prescribed insulin doses for the following 24 hours. 
After discharge, families could contact a diabetes nurse for 
counselling by phone during the daytime, five days a week, 
which was the routine procedure. During evenings, nights 
and week-ends they could receive assistance from the 
general hospital staff. The diabetes nurse offered a school 
visit with the purpose of informing teachers and school 
friends about the disease of diabetes and the treatment with 
insulin. 
Hospital-Based Home Care 
  The active ingredients in the HBHC were defined as: 
1.  a home-like environment, which allowed families to 
learn management tasks in a “hands on” fashion such 
as selecting food, trying to anticipate the effect of 
food and activity on plasma glucose, understanding 
how the components relate to each other and 
evaluating the results; 
2.  individualised learning based on the need for 
knowledge, the family’s resources, and the home, 
school and work situations; 
3.  increased support after discharge by 
a.  increased access to a diabetes nurse - by telephone 
seven days/week and three home/school visits for 
all families in the intervention group, and 
b.  visits to school/home once a month during the 
follow-up for families with special concerns 
  Children randomised to HBHC left the Children’s 
Hospital after the first initial days with their parents and 
lived in a home-like environment, the Family House, until 
families felt confident to return home. The staff members at 
the Family House worked daytime and were not trained in 
nursing. A diabetes nurse was available for the family during 
parts of the day at the Family House and had daily structured 
conversations starting by identifying the families’ needs. The 
family’s learning process was based on reflective discussions 
of problems and thoughts as they came up [42, 44]. The 
family could reach the diabetes nurse on a mobile phone 
between 08 am and 10 pm during the stay at the Family 
House. If families needed to contact health care staff during 
the night, they could receive advice by phoning the general 
hospital staff. The child and the child’s parents had 
information meetings with the paediatrician, the dietician 
and the social worker, according to the Swedish national 
guidelines for paediatric diabetes [8], at the Children’s’ 
Hospital. 
  After discharge, the diabetes nurse made three home or 
school visits besides the regular diabetes check-up visits. 
Follow-up for the intervention group was then divided into 
two groups based on the results of the instrument for 
identifying psychosocial risk factors. Families with an 
expected good prognosis received the same follow-up as the 
control group, that is, the regular follow-up. Families 
assessed to have an increased need for support were offered 
one home or school visit every month by the diabetes nurse 
over and above the regular diabetes check-up visits every 
third or fourth month. All families in the intervention group 
had accessibility to telephone support during the follow-up 
by mobile phone to the diabetes nurse, seven days a week. 
Outcome Measurements 
  The hypothesis was improved metabolic control for 
children in families having received hospital-based home 
care, compared to children in families having received 
traditional hospital-based care. The primary outcome was 
metabolic control measured by HbA1c 6, 12 and 24 months 
after diagnosis, self-monitoring of blood-glucose (SMBG) 
and acute complications during the 24-month follow-up. 
Secondary outcomes were set to evaluate general stressors 
and specific stressors for the child and for the family caused 
by the child’s illness. A time axis of the trial and the follow-
up is shown in Fig. (2). Outcomes included extensive data 
from valid and reliable instruments, collected at the time of 
discharge and at 6, 12 and 24 months after inclusion for 
assessing the effectiveness, cost-effectiveness and 
understanding of the change process. Children filled in the 
forms when they were relevant for their age and were 
assisted by a research assistant if needed. The instruments 
used in the trial are shown in Table 1. Child general outcome 
included background variables and PedsQL
TM Generic Core 
Scales Child self-report [50-53], measuring generic health 
related quality of life together with The PedsQL
TM 4.0 
Generic Core Scales Parent proxy-report scales [51, 53], 
where parents estimated their child’s generic health-related 
quality of life. The generic core scales were designed to be 
integrated with disease-specific instruments. Child diabetes 
specific outcomes included PedsQL
TM Diabetes Module 
[54], measuring diabetes-specific health-related quality of 
life, both in the form of child self-reports and parent proxy-
reports. The child diabetes-specific outcome also included 
the Diabetes Family Behaviour Scale [55], measuring 
diabetes-specific family support. 
  Family outcomes were represented by the parents’ 
answers, and parents filled in the forms independently of 
each other. It generally took 35-45 minutes to complete the 
instruments at each follow-up. The family general outcome 
included background variables, SF 36 Health Utility Index 
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Mood Adjective Checklist [62], measuring parents’ mood 
states. The family general outcome also included THU-5 
[63], measuring parents’ experiences of problems and 
progress in everyday patterns as well as Family climate [64-
66]. Diabetes-specific family outcome was measured by 
PedsQL
TM  Family impact [45, 67] and Diabetes Family 
Conflict [68]. 
  The structure of the organisation was evaluated according 
to the level of parent’s satisfaction with health care using 
PedsQL
TM Health Care Satisfaction Generic Module [53, 69, 
70] as well as according to the health care costs. Costs for 
the use of hospital services were obtained from the hospital’s 
patient administrative system, hospital records and 
questionnaires. Costs of professionals’ time were determined 
by telephone logging and additional documentation of time 
spent by team members. Furthermore, information concerning 
children’s and parents’ absenteeism from work and school 
was collected. Parents’ experiences in both control and 
intervention groups were described in qualitative interviews 
8-10 months after diagnosis. 
Blinding 
  A research assistant who was not involved in the care 
assessed the outcomes and booked appointments with 
families outside the hospital to fill in the instruments. It was 
not possible to do the intervention blinded to either 
participants or to health care providers, as it was obvious 
whether the care had been the regular hospital-based care or 
the hospital-based home care. Families in hospital-based care 
and in HBHC had, for the most part, contact with different 
diabetes nurses, while the rest of the diabetes team included 
the same persons for both groups. The first author was also 
Table 1.  Instruments Used in the Trial, what they Measure, who Fills in the Forms and When 
 
Instrument  Measuring   Child  Parent  Diabetes Team  Follow-Up at 
Diabetes Family 
Behaviour Scale  
Diabetes specific family support (Child and 
Adolescent 8-18 years) 
X      After 6, 12 and 24 months 
PedsQL Generic 
Core Scales Child 
self-report  
Generic health related quality of life 
(Adolescent 13-18 year) 
X      After 6, and 24 months 
PedsQL Diabetes 
Module  
Diabetes specific health related quality of 
life (Child 5-7 years and 8-12 years, 
Adolescent 13-18 years) 
X      After 6, 12 and 24 months 
Background 
variables 
Include child gender, age and siblings and 
parental gender, age, education, income, 
family situation.  
X X   Discharge, after 6, 12 and 24 
months 
PedsQL Family 
impact  
The disease’s impact on family    X    Discharge, after 6, 12 and 24 
months 
Parents’’/nearest 
absence 
Parents’ and those nearest, absence from 
work due to the child’s diabetes 
 X    Discharge, after 6, 12 and 24 
months 
Family climate  
A list with 85 adjectives where parents’ 
mark at least 15 that best describe their 
situation 
 X    Discharge, after 6, 12 and 24 
months 
PedsQL Health 
Care Satisfaction 
Generic Module  
Parents’ satisfaction with health care    X    Discharge, after 6, 12 and 24 
months 
SF 36 Health 
Utility Index  
Parents’ health related quality of life    X    Discharge, after 12 and 24 
months 
Mood Adjective 
Checklist 
38 adjective measuring mood states    X    Discharge, after 12 and 24 
months 
Diabetes Family 
Conflict 
Diabetes related family conflict    X    After 6, 12 and 24 months 
THU-5  Hassles and uplifts in everyday patterns    X    After 6, 12 and 24 months 
The PedsQL 4.0 
Generic Core 
Scales 
 
Parent estimate their child’s generic health 
related quality of life (Child 3-12 and 
Adolescent 13-18 years) 
  X    After 6 months 
PedsQL Diabetes 
Module 
Parent estimate their child’s diabetes 
specific health related quality of life (Child 
2-4, 5-7 or 8-12 years, Adolescent 13-18 
years) 
  X    After 6 and 12 and 24 months 
Psychosocial 
Assessment Tool 
(PAT) 
Identifying psychosocial risk      X  Discharge, after 6, 12 and 24 
months Randomised Controlled Trial Comparing Hospital-Based Care  The Open Nursing Journal, 2011, Volume 5    117 
the diabetes nurse in the HBHC intervention group. There 
were four paediatricians at the department unit working with 
children diagnosed with diabetes. They alternated in taking 
on new patients and were responsible for the 
same  children  from  the time of diagnosis onwards. There 
was one dietician and one social worker in the diabetes team 
who had contact with all of the families irrespective of the 
randomisation. 
Data Analysis Plan 
  Data will be analysed by using appropriate statistical 
methods (dependent upon type and variable) for descriptive 
data as well as multivariate analysis [71]. The relationship 
between child and family outcomes, and parents’ education, 
income, and family situation will be analysed using 
descriptive statistics, rang sum test and logistic regression. 
The HBHC was comprised of different parts and we will not 
be able to explain a possible effect from a specific part in the 
programme. However, with the solid theoretical base as to 
how the intervention might bring about change we can build 
a cumulative understanding of causal mechanisms. The 
objective of the cost-effectiveness (CE) analysis is to relate 
the marginal value of alternative medical interventions in 
improving health care to the cost of the intervention. Effects 
on costs will be calculated from both the health sector 
perspective, where health and quality of life gains will be 
compared to health sector costs and from a broader societal 
perspective where parents’ days loss of working days are 
added to the cost [72]. 
DISCUSSION 
  Even well-defined interventions in health care have 
inherent complexities that can bedevil the research. With a 
detailed description of what was intended to be included in 
the treatment before the trial was carried out and a protocol 
of what the families actually received during the trial, 
analysis of which the intended treatment was to be after the 
close of the trial, is possible [32]. An optimal scientific 
situation would be to have a sufficient flow of participants to 
minimise external influences by recruiting children over a 
long period of time. A protocol of what was intended to be 
included in the treatment also became important in order to 
control for the trial not sliding in treatment over time. The 
treatment protocol was checked regularly by the first author, 
who was also responsible for the implementation of the 
survey, as well as two persons responsible for the medical 
and nursing care in the study. To reduce the risk for nesting 
in treatment, there were different diabetes nurses in the 
intervention group and in the control group. Both diabetes 
nurses had long professional experience with families and 
children with diabetes. Avoiding nesting between families 
was facilitated by a limited flow of participants. Most often 
only one family at a time with a newly diagnosed child was 
receiving care at the department unit. Furthermore, groups 
were separated after randomisation by the environment in the 
hospital-based care and the HBHC. To minimise drop-outs 
during the follow-up, the person assessing the outcomes 
offered home visits to families so they could fill in the forms. 
If the family preferred to meet at the Children’s Hospital, 
arrangement was made to combine the meeting with the 
child’s diabetes check-up visit. 
  Limitations to this study included sample size and the 
relatively long period of recruitment. Medical therapies, 
including nursing, evolve continuously and may affect the 
routine care given to families during a trial and, at the same 
time, the trial may affect the procedures of the routine care 
[35-37]. Even though multi-centre studies would offer other 
conditions concerning power, a well-conducted one-centre 
randomised controlled trial is graded to have a high level of 
evidence by the American Diabetes Association [73]. 
  Which information is shared and how it is received by 
the families from the point of view of their unique family 
situation could be important factors affecting the ways in 
which families manage to achieve the goals for diabetes 
treatment. The social background of the family has been 
shown to be one of the most important factors for metabolic 
control [3, 5-7, 12] and an important goal for research is to 
identify groups of families who are in particular need of 
increased support and to tailor this support to their needs 
[74]. By identifying important ingredients for the child’s 
long-term metabolic control, the intervention can be put into 
operation in other contexts [30, 31]. In Sweden, there has 
been a long tradition with hospital-based care when a child is 
diagnosed with type 1 diabetes and of a diabetes care with 
high standards [75, 76]. The choice of the Family House 
rather than actual home-based care was made in order to 
smoothen the transition to home, as families had indicated 
that the time after diagnosis was a difficult time for the 
whole family [16]. The HBHC was still within the 
recommendations of the Swedish national guidelines for 
paediatric diabetes [8]. The intervention was designed to be a 
structured learning process and may in the future be used as 
home-based care if found to be efficient. 
CONCLUSION 
  This study has been designed by using a clear theoretical 
framework to describe how an intervention might bring 
about change; it is designed to minimise any threats to 
validity and provide adequate reporting, which is decisive in 
order to be able to determine the validity of the results of 
complex interventions. Childhood diabetes is a chronic 
condition in which it has been shown that intensive 
management leads to better outcomes. This intensive 
management requires families and children to learn to 
perform multiple daily tasks when the child is diagnosed 
with type 1 diabetes. Even though intervention in health care 
is complex with several interacting components with 
practical and methodological difficulties, there is a need for 
randomised controlled trials to evaluate and develop better 
systems for the learning processes of families, leading to 
long-term improvement in adherence and outcome. 
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